Patrick Kinsella, a director at $PFSI, bought 2,250 shares of the company on 02-12-2026 for an estimated $200,587. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 7.0%. Following this trade, they now own 34,210 shares of this class of $PFSI stock.
$PFSI Insider Trading Activity
$PFSI insiders have traded $PFSI stock on the open market 48 times in the past 6 months. Of those trades, 1 have been purchases and 47 have been sales.
Here’s a breakdown of recent trading of $PFSI stock by insiders over the last 6 months:
- DAVID SPECTOR (Chairman & CEO) has made 0 purchases and 21 sales selling 106,161 shares for an estimated $13,596,246.
- DANIEL STANLEY PEROTTI (Chief Financial Officer) has made 0 purchases and 18 sales selling 56,671 shares for an estimated $7,215,870.
- DOUG JONES (Director, President & CMBO) has made 0 purchases and 4 sales selling 47,771 shares for an estimated $6,188,662.
- ANNE MCCALLION has made 0 purchases and 2 sales selling 27,771 shares for an estimated $3,653,395.
- DEREK STARK (Chief Legal Officer) sold 4,750 shares for an estimated $520,410
- GREGORY L HENDRY (MD, Chief Accounting Officer) sold 3,530 shares for an estimated $464,689
- PATRICK KINSELLA purchased 2,250 shares for an estimated $200,587
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PFSI Hedge Fund Activity
We have seen 129 institutional investors add shares of $PFSI stock to their portfolio, and 119 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,050,224 shares (+73.8%) to their portfolio in Q3 2025, for an estimated $130,101,749
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 675,717 shares (-15.3%) from their portfolio in Q3 2025, for an estimated $83,707,821
- PRICE T ROWE ASSOCIATES INC /MD/ added 536,825 shares (+347.7%) to their portfolio in Q3 2025, for an estimated $66,501,881
- 140 SUMMER PARTNERS LP added 446,140 shares (+inf%) to their portfolio in Q3 2025, for an estimated $55,267,823
- BALYASNY ASSET MANAGEMENT L.P. removed 286,123 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $35,444,917
- TWO SIGMA INVESTMENTS, LP added 286,019 shares (+1148.7%) to their portfolio in Q3 2025, for an estimated $35,432,033
- CONVERSANT CAPITAL LLC removed 266,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $32,952,080
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PFSI Revenue
$PFSI had revenues of $538M in Q4 2025. This is an increase of 14.44% from the same period in the prior year.
You can track PFSI financials on Quiver Quantitative's PFSI stock page.
$PFSI Analyst Ratings
Wall Street analysts have issued reports on $PFSI in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/30/2026
- Barclays issued a "Overweight" rating on 01/30/2026
- Piper Sandler issued a "Overweight" rating on 01/30/2026
- BTIG issued a "Buy" rating on 12/29/2025
To track analyst ratings and price targets for $PFSI, check out Quiver Quantitative's $PFSI forecast page.
$PFSI Price Targets
Multiple analysts have issued price targets for $PFSI recently. We have seen 8 analysts offer price targets for $PFSI in the last 6 months, with a median target of $136.5.
Here are some recent targets:
- George Bose from Keefe, Bruyette & Woods set a target price of $115.0 on 02/02/2026
- Donald Fandetti from Wells Fargo set a target price of $135.0 on 01/30/2026
- Terry Ma from Barclays set a target price of $136.0 on 01/30/2026
- Crispin Love from Piper Sandler set a target price of $137.0 on 01/30/2026
- Eric Hagen from BTIG set a target price of $150.0 on 12/29/2025
- Matthew Hurwit from Jefferies set a target price of $160.0 on 12/19/2025
- Douglas Harter from UBS set a target price of $145.0 on 10/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
